Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

Biomedicine Archive

  • Dual-Mode Vaccines

    Vaxinnate’s vaccines may provide better stimulation of the immune system.

  • Generic Biotech

    Biotech drugs can cost hundreds of thousands of dollars a year. Cheaper generic versions could save countless lives, but proving their safety and effectiveness is no easy task.

  • The Nine-Year Itch

    Sure, spam is a scourge. It’s too bad a Virginia jury’s tough sentence for a convicted spammer won’t make a difference.

  • Vaccine Truth or Dare

    A new vaccine in the works could prevent cervical cancer. But will it ever reach those who would benefit most?

  • Of Doctors, Drugs, and Trust

    Too many doctors write prescriptions while under the influence of drug companies. Aggressive prosecution of the worst cases could help mend doctor-patient trust.

  • Taking Media in Our Own Hands

    Grassroots creative communities are creating new forms of digital expression that are influencing both the art world and commercial culture.

  • Heart Restart

    Bernard Lown’s defibrillator has jolted patients back to life for more than 40 years.

Pages

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me